Physician profile
David Mayman
NPI 1407882921
$5,467,345.59
in general payments reported to CMS, 2019-2025
15 companies · $1.3M in 2025
The $1.3M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86K · 2020: $97K · 2021: $647K · 2022: $719K · 2023: $1.1M · 2024: $1.5M · 2025: $1.3M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3.8M · Consulting Fee: $40K · Travel and Lodging: $28K · Food and Beverage: $6,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,844,464.11 |
| Consulting Fee | $40,375.00 |
| Travel and Lodging | $27,878.87 |
| Food and Beverage | $6,544.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,281,862.16 | 2019-2025 | Mako, Insignia, Trident |
| Smith+Nephew, INC. | $1,058,780.94 | 2019-2025 | Navio, Journey II, Real Intelligence |
| Orthalign INC | $597,367.69 | 2019-2025 | Orthalign Plus |
| Encore Medical, Lp | $528,374.03 | 2021 | |
| Globus Medical, INC. | $414.00 | 2025 | Excelsius Gps |
| Wishbone Medical INC. | $122.43 | 2022 | |
| Kci USA, INC. | $108.36 | 2019 | |
| Overture Orthopaedics | $61.98 | 2025 | Overtureti |
| Medical Device Business Services, INC. | $56.30 | 2023 | Attune |
| Convatec INC. | $52.62 | 2022 | |
| Ferring Pharmaceuticals INC. | $49.02 | 2019-2020 | |
| Insight Medical Systems, INC. | $45.00 | 2019-2020 | |
| Bone Support INC. | $20.00 | 2025 | Ceramentbone Void Filler, Cerament G |
| Depuy Synthes Sales INC. | $18.10 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$955,399.52 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mayman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.